Alzheimer's disease
Biomarker-Based Dx for Alzheimer's Rise as Study Results Question Effectiveness in Different Races
Premium
A paper published last month found that blood-based biomarkers used in diagnostic tests for Alzheimer's may not work as well in African American patients.
Fujirebio Alzheimer's Test Approval Offers Alternative to Imaging, Could Speed Plasma Marker Efforts
Premium
The test, which measures β-amyloid in cerebrospinal fluid, received FDA de novo classification, making it the first IVD available for detection of brain amyloid plaques.
Fujirebio Gets FDA De Novo Classification for Lumipulse Alzheimer's Test
The test is the first in vitro diagnostic the FDA has allowed to be marketed for the early detection of the amyloid plaques associated with Alzheimer's disease.
Quest Diagnostics Survey Indicates Strong Interest Among Doctors for Blood-Based Alzheimer's Tests
The survey of 501 primary care physicians, which accompanies the launch of Quest's blood-based AD test, found large majorities are interested in using such tests.
The firm has plans for multiple new tests, including blood-based Alzheimer's disease tests and another test for SARS-CoV-2.